To Compare Dexmedetomidine And Magnesium Sulphates As Adjuvants With Levobupivacaine For Spinal Anaesthesia in Infraumblical Surgeries.

Randomized Controlled Trial To Compare Dexmedetomidine And Magnesium Sulphate As Adjuvants With Levobupivacaine For Spinal Anesthesia in Infraumblical Surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057357

Enrollment

Registered

2023-09-11

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intrathecal levobupivacaine with dexmedetomidine: 3ml of 0.5% levobupivacaine and 10 microgram of dexmedetomidine (0.1ml) will be given by intrathecal route at the beginning of the surg

Eligibility

Inclusion criteria

Inclusion criteria: ASA I/II, infraumblical surgeries for <3 hour

Exclusion criteria

Exclusion criteria: Hepatic/ renal disease, uncontrolled diabetic/ hypertension, allergy to opioids, receiving magnesium, use of another analgesia like nerve block or epidural anaesthesia.

Design outcomes

Primary

Measure	Time frame
Comparison of onset & duration of sensory block of dexmedetomidine & magnesium sulphate as adjuvant to levobupivacaine after subarachnoid block in infraumblical surgeriesTimepoint: 3 hours	—

Secondary

Measure	Time frame
Comparison of onset & duration of motor block of dexmedetomidine & magnesium sulphate as adjuvant to levobupivacaine after subarachnoid block in infraumblical surgeriesTimepoint: 3 hours	—

Countries

India

Contacts

Public ContactAmit kumar

University college of medical science

amitkumarver485@gmail.com08975543537

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026